SEC Info - Bristol Myers Squibb Co. - ‘8-K’ for 3/1/21

SEC Info℠

Home

Help

Please Sign In

Bristol Myers Squibb Co. – ‘8-K’ for 3/1/21 – ‘EX-101.SCH’

On: Thursday, 3/4/21, at 4:30pm ET · For: 3/1/21 · Accession #: 1140361-21-7317 · File #: 1-01136

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/04/21  Bristol Myers Squibb Co.          8-K:5,9     3/01/21   11:212K                                   Edgarfilings Ltd.

Current Report — Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     31K 
 7: R1          Document and Entity Information                     HTML     57K 
 9: XML         IDEA XML File -- Filing Summary                      XML     12K 
 6: XML         XBRL Instance -- brhc10021324_8k_htm                 XML     25K 
 8: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 3: EX-101.DEF  XBRL Definitions -- bmy-20210301_def                 XML     52K 
 4: EX-101.LAB  XBRL Labels -- bmy-20210301_lab                      XML     79K 
 5: EX-101.PRE  XBRL Presentations -- bmy-20210301_pre               XML     56K 
 2: EX-101.SCH  XBRL Schema -- bmy-20210301                          XSD     17K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               16±    22K 
11: ZIP         XBRL Zipped Folder -- 0001140361-21-007317-xbrl      Zip     14K

‘EX-101.SCH’ — XBRL Schema — bmy-20210301

This Exhibit is an XBRL XML File.

<?xml version="1.0" encoding="windows-1252"?>

<xs:schema targetNamespace="http://bms.com/20210301" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:bmy="http://bms.com/20210301" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:srt-types="http://fasb.org/srt-types/2019-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31">

<xs:annotation>

<xs:appinfo>

<link:linkbaseRef xlink:type="simple" xlink:href="bmy-20210301_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>

<link:linkbaseRef xlink:type="simple" xlink:href="bmy-20210301_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>

<link:linkbaseRef xlink:type="simple" xlink:href="bmy-20210301_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>

<link:roleType roleURI="http://bms.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">

<link:definition> 000100 - Document - Document and Entity Information </link:definition>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

</xs:appinfo>

</xs:annotation>

<xs:import namespace="http://fasb.org/us-gaap/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd"/>

<xs:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>

<xs:import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd"/>

<xs:import namespace="http://xbrl.sec.gov/currency/2019-01-31" schemaLocation="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd"/>

<xs:import namespace="http://xbrl.sec.gov/exch/2019-01-31" schemaLocation="https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd"/>

<xs:import namespace="http://xbrl.sec.gov/naics/2017-01-31" schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd"/>

<xs:import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="https://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd"/>

<xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>

<xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"/>

<xs:import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd"/>

<xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>

<xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd"/>

<xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>

<xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>

<xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>

<xs:import namespace="http://fasb.org/us-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd"/>

<xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd"/>

<xs:import namespace="http://fasb.org/srt/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd"/>

<xs:import namespace="http://fasb.org/srt-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd"/>

<xs:element name="CelgeneContingentValueRightsMember" id="bmy_CelgeneContingentValueRightsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>

<xs:element name="One000NotesDue2025Member" id="bmy_One000NotesDue2025Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>

<xs:element name="One750NotesDue2035Member" id="bmy_One750NotesDue2035Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration"/>

</xs:schema>

9 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/16/24  Bristol-Myers Squibb Co.          424B5                  2:1.2M                                   Broadridge Fin’l So… Inc
 2/13/24  Bristol-Myers Squibb Co.          424B2                  1:856K                                   Broadridge Fin’l So… Inc
11/01/23  Bristol-Myers Squibb Co.          424B5                  2:927K                                   Broadridge Fin’l So… Inc
10/30/23  Bristol-Myers Squibb Co.          424B3                  1:818K                                   Broadridge Fin’l So… Inc
 2/17/22  Bristol-Myers Squibb Co.          424B5                  2:878K                                   Broadridge Fin’l So… Inc
 2/15/22  Bristol-Myers Squibb Co.          424B3                  1:789K                                   Broadridge Fin’l So… Inc
12/13/21  Bristol-Myers Squibb Co.          S-3ASR     12/13/21    4:554K                                   Broadridge Fin’l So… Inc
 5/04/21  Bristol-Myers Squibb Co.          S-8         5/04/21    3:81K                                    Broadridge Fin’l So… Inc
 5/04/21  Bristol-Myers Squibb Co.          S-8 POS     5/04/21    3:85K                                    Broadridge Fin’l So… Inc

↑Top